<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000044897"><TermName>Biomed 101</TermName><TermPronunciation>(BY-oh-MED â€¦)</TermPronunciation><TermDefinition><DefinitionText>A substance that is being studied for its ability to decrease the side effects of interleukin-2 (IL-2).</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000706108" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Biomed 101&quot;" language="en" id="_3"/><MediaLink ref="CDR0000706107" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Biomed 101&quot;" language="es" id="_4"/><SpanishTermName>Biomed 101</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio por su capacidad de disminuir los efectos secundarios de la interleucina-2 (IL-2).</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition></GlossaryTerm>
